Bank of America
CDMO

Bank of America’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Bank of America’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-557
Closed -$5K – 8023
2014
Q3 		$5K Buy
557
+486
+685% +$5.44K ﹤0.01% 7558
2014
Q2 		$1K Sell
71
-2,086
-97% -$26.3K ﹤0.01% 7931
2014
Q1 		$29K Sell
2,157
-100
-4% -$1.32K ﹤0.01% 6728
2013
Q4 		$22K Buy
2,257
+1,043
+86% +$9.81K ﹤0.01% 6986
2013
Q3 		$12K Sell
1,214
-1,543
-56% -$15.3K ﹤0.01% 7107
2013
Q2 		$25K Buy
+2,757
New +$28.9K ﹤0.01% 6882

Other funds holding CDMO

TCWM
Total Clarity Wealth Management St. Charles, Illinois $515M AUM 27.37% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Bank of America's CDMO Position: Q1 2025 in Review

Bank of America sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2025, closing a stake of 246,122 shares — an estimated $3.04M sold.

Bank of America first reported a position in CDMO in Q2 2013 and held it in 47 quarters. The position peaked at $8.17M in Q1 2023. 2 funds tracked by Wall St. Rank hold CDMO as of Q1 2025.

  • Bank of America reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Bank of America sold 246,122 Avid Bioservices, Inc. Common Stock shares in Q1 2025, an estimated $3.04M.
  • Bank of America first reported a position in Avid Bioservices, Inc. Common Stock in Q2 2013 and held it in 47 quarters.
  • Bank of America's Avid Bioservices, Inc. Common Stock position peaked at $8.17M in Q1 2023.
  • 2 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2025.

Based on Bank of America's 13F filing for Q1 2025, filed 15 May 2025.